Drug profile

The FDA adverse-event record for Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp

123 FDA reports name Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp, a high-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#700 of 2,679
by report volume (all drugs)
123
adverse-event reports
0.8%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp ranks #699 of 2679 by total reports (123) and #1083 of 1130 by death-coded share (0.8%). National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#699
This drug, reports of 2679
#1083
This drug, death share of 1130

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp has 123 reports now versus 100 in that prior snapshot: 23 more (23.0%).

Report change
+23
Death-coded reports
+0
Death-coded share
−0.2 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp changes

Signature read: Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp's 0.8% death-coded share is among the lowest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
123
Total Reports
1
Deaths Reported
0.8%
Death-coded share of reports

Active Ingredients

Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp

Administration Routes

Auricular (Otic)TopicalOral

Species Affected

Dog 121
Cat 2

Most Affected Breeds

Retriever - Labrador 15
Dog (unknown) 8
Terrier (unspecified) 8
Terrier - Yorkshire 8
American Pit Bull Terrier 6
Shepherd Dog - German 5
Bulldog - English 5
Maltese 4
Dog (other) 3
Boxer (German Boxer) 3

Most Reported Reactions

Loss of hearing 57
Deafness 45
Lack of efficacy - NOS 11
Hearing decreased 6
Not himself/herself 6
Hearing affected 5
Application site pain 5
Lethargy (see also Central nervous system depression in Neurological) 4
Application site inflammation 4
Impaired hearing 4
Application site reaction NOS 4
Drug administration duration too long 3

Outcome Breakdown

Recovered with Sequela
53 (43.1%)
Outcome Unknown
50 (40.7%)
Recovered/Normal
16 (13.0%)
Ongoing
3 (2.4%)
Euthanized
1 (0.8%)

Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

High-volume nationwide drug peers

Two openFDA-derived peer sets for Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp, both floored at ≥50 reports so the neighborhoods stay in the advertised mass.

What to do with this drug

  • Compare Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp's report volume and death-coded share against similar drugs nationwide. See similar drugs
  • Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
  • Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Gentamicin Sulfate, Usp; Mometasone Furoate Anhydrous, Usp; Clotrimazole, Usp (#700 of 2,679 by report volume); death-coded 0.8%. PlainBreed drug row · death-coded share stamp 0.8% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →